Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bublak, R. Melanom: Triplekombi mit Atezolizumab noch ohne Überlebensvorteil. hautnah dermatologie 39, 19–21 (2023). https://doi.org/10.1007/s15012-023-7759-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15012-023-7759-8